Atrium Therapeutics (RNA) P/E
Atrium Therapeutics (RNA) P/E from Feb 27, 2026 to Jul 20, 2026. The TTM Atrium Therapeutics (RNA) P/E is -12.10. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Atrium Therapeutics (RNA)
| Year | P/E | Change |
|---|---|---|
| 2026 | -12.10 | N/A |
Comparison Atrium Therapeutics (RNA) P/E with competitors
Atrium Therapeutics (RNA) P/E is -12.10.